Financials
Reported figures only · latest: Q4 2025
USD · US GAAP
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | $475.7M | $78.3M |
|---|
| FY24 | $401.2M | −$283M |
|---|
| FY23 | $325.1M | −$81.1M |
|---|
| FY22 | $270.7M | $120.8M |
|---|
| FY21 | $246.2M | $71.4M |
|---|
| FY20 | $194.9M | - |
|---|
| FY19 | $171.9M | −$1.9M |
|---|
| FY18 | - | - |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY25 | 84.2% | 14% | 16.5% |
|---|
| FY24 | 84.4% | 14.2% | −70.5% |
|---|
| FY23 | 83.6% | 10.2% | −24.9% |
|---|
| FY22 | 81.3% | 0.4% | 44.6% |
|---|
| FY21 | 82.7% | 5.6% | 29% |
|---|
| FY20 | 80.6% | 4.7% | - |
|---|
| FY19 | 79.2% | −0.9% | −1.1% |
|---|
| FY18 | - | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | $160.3M |
|---|
| FY24 | $123.6M |
|---|
| FY23 | $96.8M |
|---|
| FY22 | $13.7M |
|---|
| FY21 | $30.9M |
|---|
| FY20 | $60.3M |
|---|
| FY19 | $9.9M |
|---|
| FY18 | - |
|---|
Returned to shareholdersDividends paid and shares bought backShow the numbers
| Year | Dividends | Buybacks |
|---|
| FY25 | - | - |
|---|
| FY24 | - | - |
|---|
| FY23 | $0 | - |
|---|
| FY22 | $0 | $0 |
|---|
| FY21 | $100M | $0 |
|---|
| FY20 | $10M | $85K |
|---|
| FY19 | $25M | $808K |
|---|
| FY18 | - | - |
|---|
Net margin vs the sectorMedian of Technology companies filing with the SEC- Cellebrite DI Ltd.
- Technology median
Show the numbers
| Year | Cellebrite DI Ltd. | Technology median |
|---|
| FY25 | 16.5% | −2.3% |
|---|
| FY24 | −70.5% | −5% |
|---|
| FY23 | −24.9% | −6.7% |
|---|
| FY22 | 44.6% | −4.4% |
|---|
| FY21 | 29% | −1.7% |
|---|
| FY20 | - | −3% |
|---|
| FY19 | −1.1% | 0% |
|---|
| FY18 | - | 0.8% |
|---|